Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, CXCR4 | 7 | 2019 | 69 | 3.390 |
Why?
|
| Heart Failure | 4 | 2019 | 235 | 1.650 |
Why?
|
| Myocytes, Cardiac | 7 | 2019 | 166 | 1.550 |
Why?
|
| Chemokine CXCL12 | 5 | 2019 | 29 | 1.410 |
Why?
|
| Myocardium | 4 | 2017 | 235 | 1.020 |
Why?
|
| Isoproterenol | 5 | 2019 | 36 | 1.000 |
Why?
|
| Receptors, Adrenergic, beta | 4 | 2019 | 34 | 0.970 |
Why?
|
| Cardiomegaly | 3 | 2017 | 41 | 0.710 |
Why?
|
| Chemokines | 2 | 2015 | 97 | 0.680 |
Why?
|
| Cardiomyopathies | 1 | 2019 | 56 | 0.640 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2018 | 356 | 0.600 |
Why?
|
| Receptors, CXCR | 1 | 2017 | 6 | 0.600 |
Why?
|
| Signal Transduction | 7 | 2019 | 1908 | 0.590 |
Why?
|
| Caspase 3 | 1 | 2018 | 207 | 0.580 |
Why?
|
| Apoptosis | 3 | 2018 | 1398 | 0.580 |
Why?
|
| Cell Lineage | 2 | 2017 | 90 | 0.580 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2014 | 28 | 0.570 |
Why?
|
| Heart | 3 | 2019 | 180 | 0.500 |
Why?
|
| Neovascularization, Physiologic | 2 | 2005 | 73 | 0.480 |
Why?
|
| Gene Transfer Techniques | 2 | 2014 | 47 | 0.470 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 123 | 0.460 |
Why?
|
| Stress, Physiological | 1 | 2015 | 150 | 0.460 |
Why?
|
| Chemokine CCL2 | 2 | 2005 | 85 | 0.440 |
Why?
|
| Endothelial Cells | 2 | 2006 | 308 | 0.410 |
Why?
|
| Myocardial Ischemia | 2 | 2003 | 75 | 0.410 |
Why?
|
| Animals | 17 | 2021 | 15081 | 0.410 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2010 | 17 | 0.380 |
Why?
|
| Rats | 8 | 2021 | 3483 | 0.350 |
Why?
|
| Gene Expression Regulation | 4 | 2021 | 1015 | 0.350 |
Why?
|
| Reperfusion Injury | 1 | 2010 | 57 | 0.350 |
Why?
|
| Cell Hypoxia | 2 | 2005 | 58 | 0.320 |
Why?
|
| Mice, Knockout | 4 | 2019 | 933 | 0.300 |
Why?
|
| Dependovirus | 2 | 2019 | 12 | 0.300 |
Why?
|
| Mice | 8 | 2021 | 5913 | 0.300 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2 | 2019 | 7 | 0.300 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2005 | 161 | 0.290 |
Why?
|
| Genetic Vectors | 2 | 2019 | 158 | 0.290 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2018 | 1039 | 0.280 |
Why?
|
| Receptor, PAR-1 | 1 | 2006 | 10 | 0.270 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2021 | 1618 | 0.270 |
Why?
|
| Thrombin | 1 | 2006 | 25 | 0.270 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2005 | 15 | 0.270 |
Why?
|
| Oligopeptides | 1 | 2006 | 102 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 5 | 2014 | 1609 | 0.260 |
Why?
|
| Staurosporine | 1 | 2005 | 38 | 0.250 |
Why?
|
| Stem Cells | 1 | 2006 | 141 | 0.250 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2004 | 10 | 0.250 |
Why?
|
| Protein Kinase C | 1 | 2005 | 120 | 0.230 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2005 | 132 | 0.230 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2003 | 22 | 0.230 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2003 | 20 | 0.230 |
Why?
|
| Cell Differentiation | 2 | 2006 | 587 | 0.220 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 237 | 0.220 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2003 | 55 | 0.220 |
Why?
|
| Mitochondria | 2 | 2018 | 487 | 0.210 |
Why?
|
| Cytokines | 1 | 2005 | 602 | 0.200 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2021 | 1 | 0.200 |
Why?
|
| Sin3 Histone Deacetylase and Corepressor Complex | 1 | 2021 | 1 | 0.200 |
Why?
|
| Cells, Cultured | 5 | 2021 | 1518 | 0.190 |
Why?
|
| Calcium Channels, L-Type | 2 | 2012 | 20 | 0.190 |
Why?
|
| Cardiotonic Agents | 2 | 2014 | 37 | 0.180 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 1371 | 0.180 |
Why?
|
| Pulmonary Fibrosis | 1 | 2019 | 31 | 0.170 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2019 | 12 | 0.170 |
Why?
|
| Mitochondria, Heart | 1 | 2019 | 66 | 0.160 |
Why?
|
| Benzylamines | 1 | 2018 | 6 | 0.160 |
Why?
|
| Cardiovascular Diseases | 1 | 2004 | 664 | 0.150 |
Why?
|
| Heterocyclic Compounds | 1 | 2018 | 21 | 0.150 |
Why?
|
| Lentivirus | 1 | 2017 | 21 | 0.150 |
Why?
|
| Organogenesis | 1 | 2017 | 16 | 0.150 |
Why?
|
| Doxorubicin | 1 | 2018 | 84 | 0.150 |
Why?
|
| Humans | 9 | 2021 | 37093 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2019 | 187 | 0.150 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 37 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 173 | 0.140 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 409 | 0.130 |
Why?
|
| Phosphorylation | 2 | 2010 | 928 | 0.130 |
Why?
|
| Bone Marrow Cells | 2 | 2006 | 81 | 0.120 |
Why?
|
| Calcium | 1 | 2017 | 480 | 0.120 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2014 | 32 | 0.120 |
Why?
|
| Gene Knockout Techniques | 1 | 2014 | 51 | 0.120 |
Why?
|
| Vasoconstriction | 1 | 2013 | 42 | 0.120 |
Why?
|
| Homeostasis | 1 | 2015 | 188 | 0.110 |
Why?
|
| Stroke Volume | 1 | 2014 | 89 | 0.110 |
Why?
|
| Protein Phosphatase 1 | 1 | 2013 | 62 | 0.110 |
Why?
|
| Fibrosis | 1 | 2014 | 159 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2010 | 73 | 0.110 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2013 | 130 | 0.110 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2012 | 3 | 0.110 |
Why?
|
| Calcineurin | 1 | 2012 | 22 | 0.110 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 131 | 0.100 |
Why?
|
| Hemodynamics | 1 | 2012 | 91 | 0.100 |
Why?
|
| Cell Death | 2 | 2003 | 267 | 0.100 |
Why?
|
| Cell Movement | 1 | 2015 | 571 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 448 | 0.090 |
Why?
|
| Tetrazolium Salts | 1 | 2010 | 36 | 0.090 |
Why?
|
| Adenoviridae | 1 | 2010 | 62 | 0.090 |
Why?
|
| Heart Injuries | 1 | 2010 | 11 | 0.090 |
Why?
|
| Cyclic AMP | 1 | 2010 | 131 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2010 | 86 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2012 | 859 | 0.090 |
Why?
|
| Male | 5 | 2013 | 20025 | 0.090 |
Why?
|
| Arrestins | 1 | 2008 | 27 | 0.080 |
Why?
|
| Hirudins | 1 | 2006 | 2 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2006 | 121 | 0.070 |
Why?
|
| Cadherins | 1 | 2006 | 90 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 539 | 0.060 |
Why?
|
| Integrin alpha2 | 1 | 2005 | 3 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2005 | 10 | 0.060 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2005 | 14 | 0.060 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2005 | 12 | 0.060 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2004 | 9 | 0.060 |
Why?
|
| Fibroblast Growth Factors | 1 | 2004 | 33 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2005 | 343 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 218 | 0.060 |
Why?
|
| Radiation Chimera | 1 | 2003 | 7 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 1 | 2003 | 15 | 0.060 |
Why?
|
| Adoptive Transfer | 1 | 2003 | 48 | 0.060 |
Why?
|
| Organ Specificity | 1 | 2003 | 129 | 0.060 |
Why?
|
| Neutrophils | 1 | 2003 | 131 | 0.050 |
Why?
|
| Chemokine CXCL2 | 1 | 2002 | 11 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2003 | 661 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2002 | 70 | 0.050 |
Why?
|
| Methylation | 1 | 2021 | 113 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2003 | 225 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2006 | 1198 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2002 | 513 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 90 | 0.040 |
Why?
|
| Inflammation | 1 | 2003 | 618 | 0.040 |
Why?
|
| Zinc Fingers | 1 | 1998 | 26 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2019 | 272 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 239 | 0.040 |
Why?
|
| Gene Expression | 1 | 2019 | 674 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1998 | 286 | 0.030 |
Why?
|
| Mammary Arteries | 1 | 2013 | 3 | 0.030 |
Why?
|
| Femoral Artery | 1 | 2013 | 12 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 2013 | 28 | 0.030 |
Why?
|
| Vascular Diseases | 1 | 2013 | 30 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2013 | 85 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2013 | 101 | 0.030 |
Why?
|
| Transcription Factors | 1 | 1998 | 681 | 0.030 |
Why?
|
| Phenotype | 1 | 2013 | 689 | 0.020 |
Why?
|
| Proteins | 1 | 2013 | 369 | 0.020 |
Why?
|
| Muscle Cells | 1 | 2008 | 11 | 0.020 |
Why?
|
| Clathrin | 1 | 2008 | 21 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2008 | 212 | 0.020 |
Why?
|
| Kinetics | 1 | 2008 | 708 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2008 | 381 | 0.020 |
Why?
|
| Peptides | 1 | 2008 | 320 | 0.020 |
Why?
|
| Protein Binding | 1 | 2008 | 972 | 0.020 |
Why?
|
| Models, Biological | 1 | 2008 | 677 | 0.020 |
Why?
|
| GATA5 Transcription Factor | 1 | 1998 | 1 | 0.010 |
Why?
|
| GATA6 Transcription Factor | 1 | 1998 | 1 | 0.010 |
Why?
|
| GATA4 Transcription Factor | 1 | 1998 | 6 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1998 | 74 | 0.010 |
Why?
|
| Morphogenesis | 1 | 1998 | 50 | 0.010 |
Why?
|